2m 2m 2m 2m 2m 2m 2m
SERA PROGNSTCS-A (SERA)
NASDAQ
$2.03$0.00 (0.00%)
Price as of Sep 11, 2026 7:30 PM EDT- $78.1MMarket Cap
- -34.52%1-Year Change
- Medical DevicesIndustry
SERA PROGNSTCS-A (SERA)
$2.03$0.00 (0.00%)
SERA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.03 | ||
Change | -$0.02 (-0.98%) | ||
Open | $2.05 | ||
High | $2.06 | ||
Low | $2.00 | ||
Previous Close | $2.05 | ||
Volume | 26,356 | ||
30-Day Average Volume | 24,561 | ||
1-Week Change | 0.50% | ||
1-Month Change | 2.01% | ||
1-Year Change | -34.52% | ||
3-Year Change | 26.09% | ||
5-Year Change | -79.43% | ||
Fundamentals | |||
Shares Outstanding | 38.5M | ||
Total Assets | $86.7M | ||
Market Cap | $78.1M | ||
Enterprise Value | $73.7M | ||
Period: QTR TTM FY | |||
Revenue | $30,000.00 | ||
Net Income | -$9.1M | ||
Free Cash Flow | -$6.3M | ||
EBIT | -$9.1M | ||
EBITDA | -$8.9M | ||
Net Working Capital | $23.8M | ||
EPS | -$0.18 | ||
Enterprise Value/EBITDA | -8 | ||
Enterprise Value/Revenue | 2,457 | ||
P/B | 1 | ||
P/E | -11 | ||
PEG | 2 | ||
Price/Free Cash Flow | -12 | ||
Price/Operating Cash Flow | -12 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue